Biotech Boulevard
Startups and Spinouts
GEN's Biotech Boulevard highlights new entrepreneurial biotech firms based all over the globe. These unique companies are developing breakthrough products that will expand and enhance the biotech industry.
Discover, invest, and collaborate with these industry leaders of tomorrow.
Explore Biotech Boulevard. It's paved with opportunities!
GEN's Biotech Boulevard
All  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z   0  1  2  3  4  5  6  7  8  9   
  • Meritage Pharma www.MeritagePharma.com

    Meritage Pharma is committed to the development of prescription products for the treatment of gastrointestinal and atopic diseases. The company is currently developing oral budesonide suspension (OBS) intended for the treatment of eosinophilic esophagitis, an allergic inflammation of the gastrointestinal tract.

  • MiReven www.mireven.com.au

    MiReven was formed in 2010 through an investment from the Medical Research Commercialization Fund. The company is commercializing the pioneering work of Peter Leedman and Dr. Keith Giles at the Western Australian Institute for Medical Research (WAIMR) on the anti-cancer potential of miR-7. According to the company, miR-7 can knock-out an essential growth receptor for cancer, known as the epidermal growth factor receptor, as well as its associated signaling pathways that promote cancer development.

  • Molecular Response www.molecularresponse.com

    Molecular Response is an oncology-focused CRO, with a viable primary tumor bank of more than 140,000 clinical biopsies, spanning 76 diagnoses. Tumors are employed to create Patient-Derived Xenograft (PDX) models, 3D cell culture for ex-vivo pharmacology studies, and genomic surveys for target prevalence. Tumors have histology/pathology reports, ex-vivo drug resistance data and matched FFPE blocks. These platforms allow for in vivo and ex-vivo drug candidate selection, patient stratification, biomarker verification, and development of Companion Diagnostic assays in CAP/CLIA-accredited labs.

© 2012 Genetic Engineering & Biotechnology News. All Rights Reserved.
Back to www.genengnews.com